Holocene Advisors, LP Regeneron Pharmaceuticals, Inc. Transaction History

Holocene Advisors, LP

13 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2024 May 15, 2024	SELL	$902.69 - $993.35 $252 Million - $277 Million	-278,623 Reduced 77.29%	81,857 $78.8 Million
Q4 2023 Feb 14, 2024	BUY	$775.18 - $881.7 $142 Million - $161 Million	182,727 Added 102.8%	360,480 $317 Million
Q3 2023 Nov 14, 2023	BUY	$692.45 - $844.37 $11.7 Million - $14.3 Million	16,891 Added 10.5%	177,753 $146 Million
Q2 2023 Aug 14, 2023	BUY	$700.03 - $830.35 $22.8 Million - $27.1 Million	32,613 Added 25.43%	160,862 $116 Million
Q1 2023 May 15, 2023	BUY	$680.49 - $826.97 $38.2 Million - $46.4 Million	56,073 Added 77.69%	128,249 $105 Million
Q4 2022 Feb 14, 2023	BUY	$705.89 - $766.39 $50.9 Million - $55.3 Million	72,176 New	72,176 $52.1 Million
Q1 2021 May 17, 2021	SELL	$446.73 - $548.2 $669,201 - $821,203	-1,498 Closed	0 $0
Q4 2020 Feb 16, 2021	BUY	$478.3 - $607.98 $716,493 - $910,754	1,498 New	1,498 $724,000
Q3 2020 Nov 16, 2020	SELL	$544.75 - $658.21 $67 Million - $80.9 Million	-122,952 Closed	0 $0
Q2 2020 Aug 14, 2020	BUY	$493.32 - $643.92 $60.7 Million - $79.2 Million	122,952 New	122,952 $76.7 Million
Q2 2018 Aug 14, 2018	SELL	$284.6 - $344.99 $214,019 - $259,432	-752 Closed	0 $0
Q1 2018 May 15, 2018	SELL	$315.82 - $393.78 $509,417 - $635,167	-1,613 Reduced 68.2%	752 $259,000
Q4 2017 Feb 14, 2018	BUY	$358.63 - $469.95 $848,159 - $1.11 Million	2,365	2,365 $889,000

1,529

84.1M

1.22M

1.51M

Ticker REGN
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 107,190,000
Market Cap $81.1B
Description
Regeneron Pharmaceuticals, Inc. discovers, invents, develops, manufactures, and commercializes medicines for treating various diseases worldwide. The company's products include EYLEA injection to treat wet age-related macular degeneration and diabetic macular edema; myopic choroidal neovascularization; and diabetic retinopathy, as well as macula...

Get notified when there are updates to the investment portfolio of Holocene Advisors, LP, based on Form 13F filings with the SEC.

Stay updated on Holocene Advisors, LP with notifications on news.